Impaired cyclic guanosine monophosphate signaling: BayerRecent Research Landscape
Insufficient cyclic guanosine monophosphate signaling leads to ventricular stiffness and diastolic dysfunction. Restoring this pathway addresses the primary physiological deficit in heart failure with preserved ejection fraction.